These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29085358)

  • 21. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.
    Webb JR; Milne K; Nelson BH
    Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
    J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients.
    Zhang Y; Ma C; Wang M; Hou H; Cui L; Jiang C; Sun J; Qu X
    Clin Transl Oncol; 2017 Apr; 19(4):477-488. PubMed ID: 27718154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative radiotherapy contributes to induction of proliferative activity of CD8+ tumor-infiltrating T-cells in oral squamous cell carcinoma.
    Suwa T; Saio M; Umemura N; Yamashita T; Toida M; Shibata T; Takami T
    Oncol Rep; 2006 Apr; 15(4):757-63. PubMed ID: 16525655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.
    Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD
    Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
    Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
    Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
    Li J; Wang J; Chen R; Bai Y; Lu X
    Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.
    Djenidi F; Adam J; Goubar A; Durgeau A; Meurice G; de Montpréville V; Validire P; Besse B; Mami-Chouaib F
    J Immunol; 2015 Apr; 194(7):3475-86. PubMed ID: 25725111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
    Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
    Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases.
    Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I
    Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer.
    Väyrynen JP; Kantola T; Väyrynen SA; Klintrup K; Bloigu R; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
    Int J Cancer; 2016 Jul; 139(1):112-21. PubMed ID: 26874795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma.
    Lin CT; Tung CL; Tsai YS; Shen CH; Jou YC; Yu MT; Wu SF
    Urol Oncol; 2012 Sep; 30(5):680-7. PubMed ID: 21420334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
    Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
    Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.